In this study, a serial day rapid kindling protocol was used to fully kindle rats in a matter of days. Subsequently, the anticonvulsant profile of a relatively new anti-epileptic drug, topiramate, was evaluated in a cross-over design to further validate this rapid kindling model. Methods: Rats were kindled during three consecutive days, according to the serial day rapid kindling protocol. Topiramate was tested at a dose of 100 mg/kg, i.p., over the next 2 days using a cross-over design. The stability of the kindled state was evaluated in all rats during two retest paradigms. During the drug-testing procedure, rats received a single i.p. injection of either topiramate or verhicle. Starting 1 h later the rats received additional kindling stimulations during which their response was measured. Results: Serial day rapid kindling induced a long lasting and stable fully kindled state that allowed for the anti-epileptic drug screening procedure. Topiramate reduced both the afterdischarge duration and ameliorated seizure semiology in the kindled rats. Discussion: Serial day rapid kindling provided a tool to rapidly kindle rats in 3 days. Using a cross-over design, clear indications on anti-epileptic activity of a given drug can be determined using few laboratory animals. # 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
from the monosaccharide D-fructose in a research project aimed at blocking gluconeogenesis, but was later on pursued for anticonvulsant properties because of its structural comparison to acetazolamide. 1, 2 In a clinical setting, TPM has been shown to reduce seizure frequency without producing serious side-effects in various types of partial and generalized epilepsy. 1 Its mechanism of action seems diverse and has not yet been fully elucidated. TPM has been shown to block voltage-dependant Na + -channels, to enhance inhibitory neurotransmission, to antagonise a kainate (KA) subtype of the glutamate receptor and to inhibit erythrocyte carbonic anhydrase--although this is considered to be more relevant to TPM's side effects than to its antiseizure activity. [1] [2] [3] [4] During the preclinical evaluation procedure, TPM was shown to display anticonvulsive effects in various animal models of epilepsy. In the traditional maximal electroshock (MES) test in mice and rats, TPM blocked seizure spread with a potency similar to the effect of established AEDs such as phenytoin (PHT) and carbamazepine (CBZ). 4 In animal models where chemoconvulsants such as pentylenetetrazole, bicuculline or picrotoxin were administered, TPM proved to be a weak or ineffective blocker of seizure generation, although it did significantly raise the seizure threshold. 4, 5 TPM was effective against both tonic and absence-like seizures in spontaneously epileptic rats (SERs) and against provoked audiogenic seizures in DBA/2 mice. 6 TPM has also been shown to effectively reduce audiogenic tonic and clonic seizures and episodes of wild running in a post-ischemia model of epilepsy in rats. 7 In rats displaying spontaneous seizures following kainic acid-induced status epilepticus, TPM displayed significant and dose-dependent anti-epileptic effects. 8 At least two studies on the effect of TPM in amygdala-kindled rats have shown a significant reduction of both the afterdischarge duration (ADD) and seizure severity score at various doses following intraperitoneal (i.p.) and oral (p.o.) administration. 9, 10 In traditional electrical kindling, daily suprathreshold stimulation through an implanted electrode (usually in one of the limbic structures) triggers focal epileptiform activity that eventually evolves into full-blown complex partial seizures over the course of two or more weeks.
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Kindling is widely used as a screening tool in AED discovery, albeit as one of the more progressed phases in anticonvulsant testing due to its laborious nature. Nevertheless, it is considered as a highly predictive model of anti-epileptic properties in potential AED.
In this study, the serial day rapid kindling with recurrent hippocampal seizures (RKRHS) protocol was used to fully kindle rats in a matter of days instead of weeks. 12, 13 Following verification of the fully kindled state during two retest paradigms, the anticonvulsant effect of a single i.p. injection of TPM was assessed in these rats.
Methods Animals
Twelve male Sprague-Dawley rats (250 g; Charles River Laboratories, Brussels, Belgium) were originally included in this study. The animals were housed under environmentally controlled conditions (12 h light/dark cycles, temperature between 20 8C and 22 8C) at the Ghent University Hospital Animal Facility. Food and water were supplied ad libitum. All animals were treated according to the guidelines approved by the European Ethics Committee (decree 86/609/CEE) and the study protocol was approved by the Experimental Animal Ethics Committee of the Ghent University Hospital.
Electrode implantation
The rats were anaesthetized with a mixture of ketamine and xylazine (80 mg/kg and 7.5 mg/kg, respectively, i.p.). The rats then were implanted with a bipolar stimulation electrode in the dentate gyrus of the right dorsal hippocampus (stereotaxic coordinates relative to bregma: À3.9 mm along the anteroposterior axis, 1.7 mm along the mediolateral axis and À4.0 mm along the dorsoventral axis), monopolar recording electrodes in the left and right hippocampus (stereotaxic coordinates relative to bregma: À5.6 mm along the anteroposterior axis, + or À4.6 mm along the mediolateral axis and À7.4 mm along the dorsoventral axis) and three epidural recording electrodes placed above the left and right os frontale (recording electrodes) and in the centre of the os occipitale (ground electrode). 14 Electrode manufacturing details have been previously published. 15 The EEG electrodes were fixed to the skull with dental acrylic cement (Simplex Rapid powder and liquid; Kemdent, Wiltshire, United Kingdom).
Kindling protocol
All experiments were carried out using a custom built video-EEG monitoring unit and an isolated constant current stimulator. One week after surgery, experiments were started. The rats were kindled during three consecutive days according to the serial day RKRHS protocol. They received 12 stimulations daily, each stimulation consisting of a 10 s train of 1 ms biphasic square wave pulses at 400 mA and 20 Hz. Consecutive stimulations were spaced 30 min apart and the kindling response was evaluated both on the EEG and semiogically.
EEG recordings were performed starting 1 min before each kindling stimulus (baseline recording) and ending 1 min after seizure termination (ictal and postictal recording). Ictal electrographic spiking activity with an amplitude of at least twice the baseline activity and originating immediately following stimulation was considered as an afterdischarge (AD). Primary hippocampal ADs were recorded over the bipolar recording electrode in the right hippocampus and their duration was measured off-line. The severity of the kindled seizures and the seizure semiology were scored following visual inspection of the animals starting 1 min before the kindling stimulus (baseline behavior) and ending 1 min after seizure termination (ictal and postictal behavior). Seizure semiology was scored by two (unblinded) scientists, who each gave their own estimate of the seizure stage. When anomalies between both opinions were noted, these were resolved through thorough discussion between the researchers to give a clear indication on seizure stage. Mean seizure severity score was determined according to a modified version of the scale of Racine. The scale of Racine was originally developed for amygdala kindling, while kindling of the hippocampus gives rise to slightly different ictal behavior. 16 Rats do not display the typical stage 1 and stage 2 seizures as described in the scale of Racine, but wet dog shakes interlaced with oral and facial automatisms instead. 16 These subtle differences between amygdala and hippocampal kindling probably reflect activation of different networks within the limbic structures and therefore, seizures were graded according to an adjusted version of the scale of Racine 
Retest paradigm
Following completion of the kindling protocol during the three consecutive days, the rats were randomly assigned to two groups: group A and group B. Retest paradigms were performed in each group of rats on the fourth and fifth day of the experiment, preceding the drug administration protocol, to verify the kindled state of the rats. Retest stimulations were numbered from 1 to 12; Retest Stimulations 1-6 were performed on day four of the experiment, Retest Stimulations 7-12 on day five of the experiment. During both paradigms, all rats received six kindling stimulations, spaced 30 min apart. Rats that consistently responded with stage 5 seizures starting from the second retest stimulation were identified as fully kindled. Rats that did not display consistent stage 5 seizures were removed from the experiment (n = 1).
Cross-over design
Following Retest Stimulations 1-6 on day four of the experiment, rats from group A received a single i.p. TPM injection while rats from group B were injected with vehicle. Following Retest Stimulations 7-12 on day five of the experiment, rats from group A received only vehicle while rats from group B were administered TPM 100 mg/kg, i.p.
Drug administration and assessment of the anti-epileptic effect of TPM
Vehicle consisted of saline (2 ml/kg, 0.9% NaCl) diluted with 5% ethanol. TPM (100 mg/kg) was dissolved in vehicle and was always administered as a single i.p. injection. This dose of TPM (100 mg/kg, i.p.) was chosen according to the clinical dosage range in patients and based on reports of the pharmacodynamic profile of TPM as established in amygdala-kindled rats. 2, 10 One hour following administration of either TPM or vehicle, six additional kindling stimulations were administered spaced 30 min apart, during which ADD and seizure semiology of the rats were monitored. These postdrug stimulations were again numbered from 1 to 12; Postdrug Stimulations 1-6 were performed on day four of the experiment, Postdrug Stimulations 7-12 on day five of the experiment.
Blood sampling and determination of TPM concentrations in rat plasma
One hour following either TPM or vehicle administration, blood samples were obtained through lateral tail vein punction. Blood was sampled in a volume of 0.5 ml per rat, stored in an ice-cooled eppendorf vial and centrifuged at 2000 Â g for 20 min at 4 8C to separate the fractions. Plasma was extracted using a micropipette in a volume of 250-400 ml/rat. The samples were then stored in a cryovial, snap-frozen at À80 8C and stored in a deep freezer at À20 8C.
The samples were later on shipped on dry ice to the Toxicology Department of AZ St.-Jan (Bruges, Belgium) and analyzed using gas chromatography mass spectrometry (GCMS) analysis under supervision of Prof. Danielle Borrey.
The plasma concentration of TPM, in plasma taken 1 h following i.p. injection of the drug, was determined at 109.3 AE 3.8 mg/ml.
Statistical analyses
For statistical processing, data from the kindling acquisition period was pooled between all eight rats. Data from day four and day of the experiment were processed for both groups of rats separately. To validate the stability of the kindled state, averaged results from Retest Stimulations 1-6 were compared to those of Retest Stimulations 7-12 per group of rats. To evaluate the effect of the TPM, averaged results per group of rats from Postdrug Stimulation 1-6 and Postdrug Stimulation 7-12 were compared to those of Retest Stimulation 1-6 and Retest Stimulation 7-12, respectively.
Results from Retest Stimulation 1 and 7 and from Postdrug Stimulation 1 and 7 were omitted from statistical analyses because these were considered build-up or rekindling stimulations, during which all rats displayed milder seizure activity.
All data is presented as mean AE standard error of the mean and was processed using statistical analyses software (SPSS; SPSS Belux, Brussels, belgium). To process the ADD, one-way ANOVA was used (parametric data, verified through a Kolgomorov-Smirnov test for normal distribution and a Levene test for homogeneity of variances). To compare seizure stages, the Mann-Whitney U-test was used (non-parametric data) combined with the Wilcoxon signed rank test.
Results
Out of the twelve rats that underwent surgery, eight were selected for the experiment based on general health of the animal, quality of the EEG recordings and their response to a test stimulation. These eight rats showed epileptiform activity on the EEG that became noticeable as an AD, increasing from a mean duration of 23.2 AE 3.1 s during the first kindling stimulation to a maximum of 117.1 AE 12.2 s at the end of the second day of kindling (24 stimulations) (Fig. 1) . Subsequently, mean ADD showed a decreasing trend towards 64.8 AE 7.6 s during the last stimulation of the kindling acquisition paradigm (Fig. 1) . The increase in ADD was accompanied by noticeable changes in the behavior of the animals; wet dog shakes, head nodding, twitching of the vibrissae and chewing became noticeable after the first stimulation (Fig. 1) . As demonstrated in Fig. 2 , rats displayed mostly stage 1-2 seizures during the first day of kindling (median seizure rank: stage 1-2, Wilcoxon). All rats showed a progressive worsening of seizure semiology: during the second day of the protocol, median seizure rank had increased to stage 4 and during the third day median seizure rank had risen to stage 5 ( Fig. 2) 
(Wilcoxon).
Following completion of the kindling acquisition protocol, the eight rats were randomly divided into two groups; group A and group B. Initially, each group consisted of four rats. Results from the retest paradigms performed on day four and five of the experiment did not reveal significant differences in the kindled state for either group A or group B. Mean ADD in group A during Retest Stimulation 1-6 (day four) was 58.5 AE 3.6 s, compared to 56.6 AE 5.2 s during Retest Stimulation 7-12 (day five) (Fig. 1) . Median seizure rank in group A was stage 5 during both retest paradigms and was not statistically different ( Fig. 2) (Wilcoxon, Mann-Whitney). Likewise, mean ADD in group B showed no statistically significant differences between the two retest paradigms: mean ADD during Retest Stimulation 1-6 was 49.3 AE 4.3 s compared to 42.1 AE 6.0 s during Retest Stimulations 7-12 ( Fig. 1) . Median seizure rank for group B was stage 5 during both retest paradigms and no statistical differences were seen (Fig. 2) (Wilcoxon, Mann-Whitney). One rat from group B was removed from the experiment and statistical processing because it did not show consistent stage 5 responses during Retest Stimulations 7-12. During Retest Stimulations 7-9 this rat only showed stage 1-2 responses and during the subsequent Retest Stimulations 10-12 it only displayed stage 4 seizures.
Following the retest paradigm on day four of the experiment, rats from group A (n = 4) were administered TPM while rats from group B (n = 3) received only vehicle. Consequently, kindling parameters were not statistically different in group B following the injection: mean ADD and median seizure rank during Postdrug Stimulations 1-6 were 52.1 AE 5.2 s and stage 5, respectively (Figs. 1 and 2 ). The rats from group A did show a significant reduction in both ADD and seizure severity during Postdrug Stimulations 1-6 compared to the results from these rats during Retest Stimulations 1-6: mean ADD dropped to 27.1 AE 3.4 s (Fig. 1) and mean seizure rank declined to stage 4 ( p < 0.05) (Fig. 2) (Wilcoxon) .
Following the retest paradigm performed on day five of the experiment, rats from group A received only vehicle while rats from group B were injected with TPM. Again, kindling parameters did not show 624
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Discussion
The use of kindling as a first line evaluation tool in the anti-epileptic screening procedure is hampered by its laborious and time-consuming nature. Traditional kindling protocols usually provide once-or twice-daily stimulations and can take weeks to accomplish. In their original publications, Lothman and coworkers described the serial day rapid kindling procedure used in this experiment and found that the serial day RKRHS protocol renders fully kindled animals faster than traditional kindling but only leads to a short lasting fully kindled state that gradually dissipates over the course of several days. This not only raised concerns whether this model compares to traditional kindling but inevitably also whether this model could be used in the AED screening procedure. [12] [13] [14] 17 The main goal of this study was to further investigate the potential benefit of using serial day rapid kindling as a fast and reliable screening model in the validation procedures for AEDs with a minimal amount of animals. In this experiment, eight rats were fully kindled within 36 stimulations, meaning that by the end of the third day of the RKRHS protocol, a batch of rats had become available for the screening procedure. By using a cross-over design, each rat served as control animal at one time and as treated animal at another.
During both retest paradigms, 7 out of 8 rats displayed consistent complex partial seizures in response to kindling stimulation. Both seizure stage and ADD did not change significantly during the retest procedures, indicating that a stable kindled state had been induced. Serial day rapid kindling therefore presents the researcher with the possibility to induce a sufficiently long lasting epileptic state in rats in a matter of days. This alternative takes up less time compared to traditional kindling protocols with once-daily stimulation and still results in a fully kindled state that persists long enough for drug testing.
The drug screening protocol performed in this experiment has shown that TPM administration results in a significant amelioration of seizure parameters in this model. Following TPM administration, epileptiform activity showed a drastic decline in both severity and duration. Mean ADD showed an average decline of 54% in group A and 78% in group B ( p < 0.05). Likewise, the rats displayed more moderate seizures following administration of TPM ( p < 0.05). In this experiment, treatment with TPM (100 mg/kg, i.p.) did not readily suppress (limbic) seizure generation but did limit seizure duration (measured by the ADD) and reduced seizure spread (measured by the amelioration of seizure semiology).
The experiment also provides some insight into the duration of the anticonvulsive effects of a single i.p. administration of TPM. TPM has a prolonged half-life of 21 h, meaning that some residual anticonvulsant effects of earlier TPM administration (on day 4) could have resulted in a noticeable carry-over effect during the subsequent testing period (on day 5). No such effects were noted in this experiment. It might however be wise to expand the interval between subsequent testing periods in the crossover design to at least two times the half-life period. Whether the kindled state elicited by the serial day rapid kindling design is stable enough to bridge between more distanced testing periods, remains to be determined.
The results of this study confirm that TPM is a potent anti-epileptic drug and provide additional proof of the usability of the serial day rapid kindling protocol as a reliable screening tool. In a previous study, this protocol has also been successfully used to study the effect of levetiracetam, another recent anti-epileptic drug. 15 Taken together, both studies suggest serial day rapid kindling could be forwarded in the drug screening process to allow for a more detailed analyses of compounds earlier in preclinical development.
In conclusion, rats kindled according to the serial day rapid kindling protocol displayed a stable fully kindled state that allows a cross-over AED screening procedure. TPM was shown to be an effective antiepileptic drug in serial day rapid kindling. This model proved to be an effective tool in screening drugs for anti-epileptic properties, yielding results over the course of only a few days.
